<div><style type="text/css">
<!--
p {margin: 0; padding: 0;} .ft10{font-size:14px;font-family:BLDIFP+TimesNewRomanPS;color:#000000;}
.ft11{font-size:27px;font-family:BLDIHA+TimesNewRomanPS;color:#000000;}
.ft12{font-size:19px;font-family:BLDIHA+TimesNewRomanPS;color:#000000;}
.ft13{font-size:8px;font-family:BLDIFP+TimesNewRomanPS;color:#000000;}
.ft14{font-size:7px;font-family:BLDIFP+TimesNewRomanPS;color:#000000;}
.ft15{font-size:12px;font-family:BLDIFP+TimesNewRomanPS;color:#000000;}
.ft16{font-size:19px;line-height:19px;font-family:BLDIHA+TimesNewRomanPS;color:#000000;}
.ft17{font-size:14px;line-height:17px;font-family:BLDIFP+TimesNewRomanPS;color:#000000;}
.ft18{font-size:12px;line-height:14px;font-family:BLDIFP+TimesNewRomanPS;color:#000000;}
.ft19{font-size:12px;line-height:12px;font-family:BLDIFP+TimesNewRomanPS;color:#000000;}
.ft110{font-size:12px;line-height:15px;font-family:BLDIFP+TimesNewRomanPS;color:#000000;}
-->
<!--
p {margin: 0; padding: 0;} .ft20{font-size:14px;font-family:BLDIFP+TimesNewRomanPS;color:#000000;}
.ft21{font-size:15px;font-family:BLDIHA+TimesNewRomanPS;color:#000000;}
.ft22{font-size:14px;font-family:BLDIKC+TimesNewRomanPS;color:#000000;}
.ft23{font-size:8px;font-family:BLDIFP+TimesNewRomanPS;color:#000000;}
.ft24{font-size:7px;font-family:BLDIFP+TimesNewRomanPS;color:#000000;}
.ft25{font-size:12px;font-family:BLDIFP+TimesNewRomanPS;color:#000000;}
.ft26{font-size:15px;line-height:17px;font-family:BLDIHA+TimesNewRomanPS;color:#000000;}
.ft27{font-size:14px;line-height:17px;font-family:BLDIFP+TimesNewRomanPS;color:#000000;}
-->
<!--
p {margin: 0; padding: 0;} .ft30{font-size:14px;font-family:BLDIFP+TimesNewRomanPS;color:#000000;}
.ft31{font-size:15px;font-family:BLDIHA+TimesNewRomanPS;color:#000000;}
.ft32{font-size:14px;font-family:BLDIHA+TimesNewRomanPS;color:#000000;}
.ft33{font-size:8px;font-family:BLDIFP+TimesNewRomanPS;color:#000000;}
.ft34{font-size:12px;font-family:BLDIFP+TimesNewRomanPS;color:#000000;}
.ft35{font-size:14px;line-height:17px;font-family:BLDIFP+TimesNewRomanPS;color:#000000;}
-->
<!--
p {margin: 0; padding: 0;} .ft40{font-size:14px;font-family:BLDIFP+TimesNewRomanPS;color:#000000;}
.ft41{font-size:15px;font-family:BLDIHA+TimesNewRomanPS;color:#000000;}
.ft42{font-size:12px;font-family:BLDIFP+TimesNewRomanPS;color:#000000;}
.ft43{font-size:14px;line-height:17px;font-family:BLDIFP+TimesNewRomanPS;color:#000000;}
-->
<!--
p {margin: 0; padding: 0;} .ft50{font-size:14px;font-family:BLDIFP+TimesNewRomanPS;color:#000000;}
.ft51{font-size:15px;font-family:BLDIHA+TimesNewRomanPS;color:#000000;}
.ft52{font-size:12px;font-family:BLDIFP+TimesNewRomanPS;color:#000000;}
.ft53{font-size:14px;line-height:17px;font-family:BLDIFP+TimesNewRomanPS;color:#000000;}
-->
<!--
p {margin: 0; padding: 0;} .ft60{font-size:14px;font-family:BLDIFP+TimesNewRomanPS;color:#000000;}
.ft61{font-size:15px;font-family:BLDIHA+TimesNewRomanPS;color:#000000;}
.ft62{font-size:8px;font-family:BLDIFP+TimesNewRomanPS;color:#000000;}
.ft63{font-size:14px;line-height:17px;font-family:BLDIFP+TimesNewRomanPS;color:#000000;}
-->
</style>
<div id="page1-div" style="position:relative;width:701px;height:1028px;">
<img width="701" height="1028" src="/Static/i/lagboken/hidden.png" alt="background image"/>
<p style="position:absolute;top:924px;left:646px;white-space:nowrap" class="ft10">1</p>
<p style="position:absolute;top:80px;left:77px;white-space:nowrap" class="ft11"><b>Svensk f�rfattningssamling</b></p>
<p style="position:absolute;top:192px;left:77px;white-space:nowrap" class="ft16"><b>F�rordning<br/>om �ndring i f�rordningen (1999:58) om f�rbud <br/>mot vissa h�lsofarliga varor;</b></p>
<p style="position:absolute;top:268px;left:77px;white-space:nowrap" class="ft10">utf�rdad den 17 december 2015.</p>
<p style="position:absolute;top:303px;left:91px;white-space:nowrap" class="ft10">Regeringen f�reskriver</p>
<p style="position:absolute;top:301px;left:224px;white-space:nowrap" class="ft13">1 att bilagan till f�rordningen (1999:58) om f�rbud</p>
<p style="position:absolute;top:320px;left:77px;white-space:nowrap" class="ft10">mot vissa h�lsofarliga varor ska ha f�ljande lydelse.</p>
<p style="position:absolute;top:356px;left:91px;white-space:nowrap" class="ft10">Denna f�rordning tr�der i kraft den 26 januari 2016.</p>
<p style="position:absolute;top:391px;left:77px;white-space:nowrap" class="ft10">P� regeringens v�gnar</p>
<p style="position:absolute;top:425px;left:77px;white-space:nowrap" class="ft10">GABRIEL WIKSTR�M</p>
<p style="position:absolute;top:443px;left:307px;white-space:nowrap" class="ft17">Lars Hedengran<br/>(Socialdepartementet) </p>
<p style="position:absolute;top:898px;left:77px;white-space:nowrap" class="ft19">1 Se Europaparlamentets och r�dets direktiv (EU) 2015/1535 av den 9 september 2015<br/>om ett informationsf�rfarande betr�ffande tekniska f�reskrifter och betr�ffande f�re-<br/>skrifter f�r informationssamh�llets tj�nster.</p>
<p style="position:absolute;top:175px;left:536px;white-space:nowrap" class="ft12"><b>SFS 2015:997</b></p>
<p style="position:absolute;top:202px;left:536px;white-space:nowrap" class="ft110">Utkom fr�n trycket<br/>den 29 december 2015</p>
</div>
<div id="page2-div" style="position:relative;width:701px;height:1028px;">
<img width="701" height="1028" src="/Static/i/lagboken/hidden.png" alt="background image"/>
<p style="position:absolute;top:924px;left:46px;white-space:nowrap" class="ft20">2</p>
<p style="position:absolute;top:51px;left:46px;white-space:nowrap" class="ft21"><b>SFS 2015:997</b></p>
<p style="position:absolute;top:51px;left:581px;white-space:nowrap" class="ft22"><i>Bilaga</i></p>
<p style="position:absolute;top:49px;left:619px;white-space:nowrap" class="ft23">2</p>
<p style="position:absolute;top:94px;left:181px;white-space:nowrap" class="ft26"><b>F�rteckning �ver varor som ska anses som h�lsofarliga varor <br/>enligt lagen om f�rbud mot vissa h�lsofarliga varor</b></p>
<p style="position:absolute;top:138px;left:196px;white-space:nowrap" class="ft27">N-metyl-1-(3,4-metylendioxifenyl)-2-butylamin (MBDB)<br/>1-(3,4-metylendioxifenyl)-2-butylamin (BDB)<br/>5-metoxi-N,N-dimetyltryptamin (5-MeO-DMT)<br/>5-metoxi-N,N-diisopropyltryptamin (5-MeO-DIPT)<br/>5-metoxi-alfametyltryptamin (5-MeO-AMT)<br/>2,5-dimetoxi-4-etylfenetylamin (2C-E)<br/>alfa-metyltryptamin (AMT)<br/>2,5-dimetoxi-4-klorfenetylamin (2C-C)<br/>2,5-dimetoxi-4-metylfenetylamin (2C-D)<br/>4-acetoxi-N,N-diisopropyltryptamin (4-AcO-DIPT)<br/>4-hydroxi-N,N-diisopropyltryptamin (4-HO-DIPT)<br/>gammabutyrolakton (GBL)<br/>1,4-butandiol (1,4-BD)<br/>4-acetoxi-N,N-metylisopropyltryptamin (4-AcO-MIPT)<br/>4-hydroxi-N,N-metylisopropyltryptamin (4-HO-MIPT)<br/>4-acetoxi-N,N-dietyltryptamin (4-AcO-DET)<br/>4-hydroxi-N,N-dietyltryptamin (4-HO-DET)<br/>1-(3-trifluormetylfenyl)piperazin (TFMPP)<br/>2,5-dimetoxi-4-isopropyltiofenetylamin (2C-T-4)<br/>[2,3-dihydro-5-metyl-3-(4-morfolinylmetyl)pyrrolo[1,2,3-de]-1,4-</p>
<p style="position:absolute;top:486px;left:181px;white-space:nowrap" class="ft20">bensoxazin-6-yl]-1-naftalenylmetanon (WIN 55,212-2)</p>
<p style="position:absolute;top:503px;left:196px;white-space:nowrap" class="ft20">5-(1,1-dimetylheptyl)-2-[5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]fenol</p>
<p style="position:absolute;top:520px;left:181px;white-space:nowrap" class="ft20">(CP 55,940)</p>
<p style="position:absolute;top:538px;left:196px;white-space:nowrap" class="ft27">(2-metyl-1-pentylindol-3-yl)-(naftalen-1-yl)metanon (JWH-007)<br/>(2-metyl-1-propyl-1H-indol-3-yl)-1-naftalenylmetanon (JWH-015)<br/>(1-hexyl-1H-indol-3-yl)-1-naftalenylmetanon (JWH-019)<br/>2-metylnaftalen-1-yl-(butylindol-3-yl)metanon (JWH-073 metylderivat)<br/>4-metoxinaftalen-1-yl-(1-pentylindol-2-metyl-3-yl)metanon (JWH-098)<br/>1-hexyl-2-fenyl-4-(1-naftoyl)pyrrol (JWH-147)<br/>(4-metoxyfenyl)(1-pentyl-1H-indol-3-yl)metanon (RCS-4)<br/>4-metylhexan-2-amin (DMAA)<br/>4-(2-aminopropyl)bensofuran (4-APB)<br/>5-(2-aminopropyl)bensofuran (5-APB)<br/>6-(2-aminopropyl)bensofuran (6-APB)<br/>(1-pentyl-1H-indol-3-yl)(2,2,3,3-tetrametylcyclopropyl)metanon </p>
<p style="position:absolute;top:747px;left:181px;white-space:nowrap" class="ft20">(UR-144)</p>
<p style="position:absolute;top:764px;left:196px;white-space:nowrap" class="ft27">1-(1-bensofuran-5-yl)-N-metylpropan-2-amin (5-MAPB)<br/>1-(5-fluoropentyl)-N-tricyklo[3.3.1.1</p>
<p style="position:absolute;top:780px;left:407px;white-space:nowrap" class="ft23">3,7]dek-1-yl-1H-indol-3-karboxamid</p>
<p style="position:absolute;top:799px;left:181px;white-space:nowrap" class="ft20">(STS-135) </p>
<p style="position:absolute;top:816px;left:196px;white-space:nowrap" class="ft20">1-pentyl-N-tricyklo[3.3.1.1</p>
<p style="position:absolute;top:814px;left:351px;white-space:nowrap" class="ft23">3,7]dek-1-yl-1H-indol-3-karboxamid<i> </i>(APICA</p>
<p style="position:absolute;top:834px;left:181px;white-space:nowrap" class="ft20">[JWH-018 adamantyl karboxamid])</p>
<p style="position:absolute;top:851px;left:196px;white-space:nowrap" class="ft20">1-pentyl-N-tricyklo[3.3.1.1</p>
<p style="position:absolute;top:849px;left:351px;white-space:nowrap" class="ft23">3,7]dek-1-yl-1H-indazol-3-karboxamid</p>
<p style="position:absolute;top:868px;left:181px;white-space:nowrap" class="ft20">(AKB48)</p>
<p style="position:absolute;top:886px;left:196px;white-space:nowrap" class="ft20">(1-pentyl-1H-indol-3-yl)tricyklo[3.3.1.1</p>
<p style="position:absolute;top:884px;left:425px;white-space:nowrap" class="ft23">3,7]dek-1-yl-metanon (AB-001)</p>
<p style="position:absolute;top:921px;left:181px;white-space:nowrap" class="ft24">2 Senaste lydelse 2015:525.</p>
</div>
<div id="page3-div" style="position:relative;width:701px;height:1028px;">
<img width="701" height="1028" src="/Static/i/lagboken/hidden.png" alt="background image"/>
<p style="position:absolute;top:924px;left:649px;white-space:nowrap" class="ft30">3</p>
<p style="position:absolute;top:51px;left:536px;white-space:nowrap" class="ft31"><b>SFS 2015:997</b></p>
<p style="position:absolute;top:51px;left:91px;white-space:nowrap" class="ft30">(1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetrametylcyklopropyl)met-</p>
<p style="position:absolute;top:68px;left:77px;white-space:nowrap" class="ft30">anon (5F-UR-144<b>)</b></p>
<p style="position:absolute;top:85px;left:91px;white-space:nowrap" class="ft35">1-(5-fluoropentyl)-1H-indol-3-karboxylsyra 8-kinolinester (5F-PB22)<br/>1-(5-fluoropentyl)-N-tricyklo[3.3.1.1</p>
<p style="position:absolute;top:101px;left:303px;white-space:nowrap" class="ft33">3,7]dek-1-yl-1H-indazol-3-karbox-</p>
<p style="position:absolute;top:120px;left:77px;white-space:nowrap" class="ft30">amid (5F-AKB48)</p>
<p style="position:absolute;top:138px;left:91px;white-space:nowrap" class="ft30">1-[(5-kloropentyl)-1H-indol-3-yl]-(naftalen-1-yl)metanon (JWH-018 </p>
<p style="position:absolute;top:155px;left:77px;white-space:nowrap" class="ft30">N-[5-kloropentyl] derivat)</p>
<p style="position:absolute;top:172px;left:91px;white-space:nowrap" class="ft30">N-[1-(aminokarbonyl)-2-metylpropyl]-1-[(4-fluorofenyl)metyl]-1H-</p>
<p style="position:absolute;top:190px;left:77px;white-space:nowrap" class="ft30">indazol-3-karboxamid (AB-FUBINACA)</p>
<p style="position:absolute;top:207px;left:91px;white-space:nowrap" class="ft30">N-(1-amino-3,3-dimetyl-1-oxobutan-2-yl)-1-((4-fluorofenyl)metyl)-1H-</p>
<p style="position:absolute;top:225px;left:77px;white-space:nowrap" class="ft30">indazol-3-karboxamid (ADB-FUBINACA)</p>
<p style="position:absolute;top:242px;left:91px;white-space:nowrap" class="ft30">N-[1-(aminokarbonyl)-2-metylpropyl]-1-(cyclohexylmetyl)-1H-indazol-3-</p>
<p style="position:absolute;top:259px;left:77px;white-space:nowrap" class="ft30">karboxamid (AB-CHMINACA)</p>
<p style="position:absolute;top:277px;left:91px;white-space:nowrap" class="ft30">N-(1-amino-3-metyl-1-oxobutan-2-yl)-1-pentyl-1H-indazol-3-karboxamid</p>
<p style="position:absolute;top:294px;left:77px;white-space:nowrap" class="ft30">(AB-PINACA)</p>
<p style="position:absolute;top:312px;left:91px;white-space:nowrap" class="ft30">N-(1-amino-3-metyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazol-3-</p>
<p style="position:absolute;top:329px;left:77px;white-space:nowrap" class="ft30">karboxamid (5F-AB-PINACA)</p>
<p style="position:absolute;top:346px;left:91px;white-space:nowrap" class="ft30">N-(1-amino-3,3-dimetyl-1-oxobutan-2-yl)-1-pentyl-1H-indol-3-karboxa-</p>
<p style="position:absolute;top:364px;left:77px;white-space:nowrap" class="ft30">mid (ADBICA)</p>
<p style="position:absolute;top:381px;left:91px;white-space:nowrap" class="ft35">kinolin-8-yl-1-pentyl-1H-indol-3-karboxylat (PB-22)<br/>kinolin-8-yl-1-(4-fluorobensyl)-1H-indol-3-karboxylat (FUB-PB-22)<br/>naftalen-1-yl-1-(4-fluorobensyl)-1H-indol-3-karboxylat (FDU-PB-22)<br/>kinolin-8-yl-1-(5-fluoropentyl)-1H-indazol-3-karboxylat (5F-PB-22</p>
<p style="position:absolute;top:451px;left:77px;white-space:nowrap" class="ft30">indazol)</p>
<p style="position:absolute;top:468px;left:91px;white-space:nowrap" class="ft35">kinolin-8-yl-1-(cyklohexylmetyl)-1H-indol-3-karboxylat (BB-22) <br/>4-hydroxi-3,3,4-trimetyl-1-(1-pentyl-1H-indol-3-yl)pentan-1-on </p>
<p style="position:absolute;top:503px;left:77px;white-space:nowrap" class="ft30">(4-HTMPIPO)</p>
<p style="position:absolute;top:520px;left:91px;white-space:nowrap" class="ft30">(1-heptyl-1H-indol-3-yl)(2,2,3,3-tetrametylcyklopropyl)metanon </p>
<p style="position:absolute;top:538px;left:77px;white-space:nowrap" class="ft30">(UR-144-heptylderivat)</p>
<p style="position:absolute;top:555px;left:91px;white-space:nowrap" class="ft35">N-bensyl-1-(5-fluoropentyl)-1H-indol-3-karboxamid (5F-SDB-006)<br/>N-bensyl-1-pentyl-1H-indol-3-karboxamid (SDB-006)<br/>N-(1-amino-3,3-dimetyl-1-oxobutan-2-yl)-1-pentyl-1H-indazol-3-</p>
<p style="position:absolute;top:607px;left:77px;white-space:nowrap" class="ft30">karboxamid (ADB-PINACA)</p>
<p style="position:absolute;top:625px;left:91px;white-space:nowrap" class="ft35">N-(naftalen-1-yl)-1-pentyl-1H-indazol-3-karboxamid (MN-18)<br/>1-(5-fluoropentyl)-N-(naftalen-1-yl)-1H-indol-3-karboxamid (5F-NNEI)<br/>N-(1-amino-3-metyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indol-3-</p>
<p style="position:absolute;top:677px;left:77px;white-space:nowrap" class="ft30">karboxamid (5F-AB-144)</p>
<p style="position:absolute;top:694px;left:91px;white-space:nowrap" class="ft35">(1-(5-fluoropentyl)-1H-indazol-3-yl)(naftalen-1-yl)metanon (THJ-2201)<br/>[1-(5-fluoropentyl)-1H-benso[d]imidazol-2-yl](naftalen-1-yl)metanon</p>
<p style="position:absolute;top:729px;left:77px;white-space:nowrap" class="ft30">(FUBIMINA)</p>
<p style="position:absolute;top:747px;left:91px;white-space:nowrap" class="ft30">metyl-2-(1-(5-fluoropentyl)-1H-indazol-3-karboxamido)-3-metylbutanoat</p>
<p style="position:absolute;top:764px;left:77px;white-space:nowrap" class="ft30">(5F-AMB)</p>
<p style="position:absolute;top:781px;left:91px;white-space:nowrap" class="ft30">1-(5-fluoropentyl)-N-(naftalen-1-yl)-1H-indazol-3-karboxamid (5F-MN-</p>
<p style="position:absolute;top:799px;left:77px;white-space:nowrap" class="ft30">18)</p>
<p style="position:absolute;top:816px;left:91px;white-space:nowrap" class="ft30">1-(5-fluoropentyl)-N-(naftalen-1-yl)-1H-pyrrolo[3,2-c]pyridin-3-karbo-</p>
<p style="position:absolute;top:834px;left:77px;white-space:nowrap" class="ft30">xamid (5F-PCN)</p>
<p style="position:absolute;top:851px;left:91px;white-space:nowrap" class="ft35">naftalen-1-yl-1-(5-fluoropentyl)-1H-indazol-3-karboxylat (5F-SDB-005)<br/>N-(1-amino-3-metyl-1-oxobutan-2-yl)-1-[(2-fluorofenyl)metyl]-1H-inda-</p>
<p style="position:absolute;top:886px;left:77px;white-space:nowrap" class="ft30">zol-3-karboxamid (AB-FUBINACA 2-fluorobensyl isomer)</p>
<p style="position:absolute;top:903px;left:91px;white-space:nowrap" class="ft30">N-(1-amino-3,3-dimetyl-1-oxobutan-2-yl)-1-(cyklohexylmetyl)-1H-inda-</p>
<p style="position:absolute;top:921px;left:77px;white-space:nowrap" class="ft30">zol-3-karboxamid (ADB-CHMINACA)</p>
</div>
<div id="page4-div" style="position:relative;width:701px;height:1028px;">
<img width="701" height="1028" src="/Static/i/lagboken/hidden.png" alt="background image"/>
<p style="position:absolute;top:924px;left:46px;white-space:nowrap" class="ft40">4</p>
<p style="position:absolute;top:51px;left:46px;white-space:nowrap" class="ft41"><b>SFS 2015:997</b></p>
<p style="position:absolute;top:51px;left:196px;white-space:nowrap" class="ft40">7-kloro-N-[1-[((2-((cyklopropylsulfonyl)amino)-etyl)amino)karbonyl]-</p>
<p style="position:absolute;top:68px;left:181px;white-space:nowrap" class="ft43">2,2-dimetyl-propyl]-1-(4-fluorobensyl)-1H-indazol-3-karboxamid (ADSB-<br/>FUB-187)</p>
<p style="position:absolute;top:103px;left:196px;white-space:nowrap" class="ft40">adamant-1-yl-(1-[(N-metylpiperidin-2-yl)metyl]-1H-indol-3-yl)metanon</p>
<p style="position:absolute;top:120px;left:181px;white-space:nowrap" class="ft40">(AM-1248)</p>
<p style="position:absolute;top:138px;left:196px;white-space:nowrap" class="ft40">N-(2-fenylpropan-2-yl)-1-(5-fluoropentyl)-1H-indol-3-karboxamid</p>
<p style="position:absolute;top:155px;left:181px;white-space:nowrap" class="ft40">(CUMYL-5F-PICA)</p>
<p style="position:absolute;top:172px;left:196px;white-space:nowrap" class="ft40">1-(5-fluoropentyl)-N-(2-fenylpropan-2-yl)-1H-indazol-3-karboxamid</p>
<p style="position:absolute;top:190px;left:181px;white-space:nowrap" class="ft40">(CUMYL-5F-PINACA, SGT-25)</p>
<p style="position:absolute;top:207px;left:196px;white-space:nowrap" class="ft43">1-butyl-N-(2-fenylpropan-2-yl)-1H-indol-3-karboxamid (CUMYL-BICA)<br/>N-(2-fenylpropan-2-yl)-1-pentyl-1H-indol-3-karboxamid (CUMYL-PICA)<br/>N-(2-fenylpropan-2-yl)-1-pentyl-1H-indazol-3-karboxamid (CUMYL-</p>
<p style="position:absolute;top:259px;left:181px;white-space:nowrap" class="ft40">PINACA)</p>
<p style="position:absolute;top:277px;left:196px;white-space:nowrap" class="ft40">N-(2-fenylpropan-2-yl)-1-((tetrahydro-2H-pyran-4-yl)metyl)-1H-indazol-</p>
<p style="position:absolute;top:294px;left:181px;white-space:nowrap" class="ft40">3-karboxamid (CUMYL-THPINACA)</p>
<p style="position:absolute;top:312px;left:196px;white-space:nowrap" class="ft40">(1-(5-fluoropentyl)-1H-indazol-3-yl)(2,2,3,3-tetrametylcyklopropyl)meta-</p>
<p style="position:absolute;top:329px;left:181px;white-space:nowrap" class="ft40">non (FAB-144)</p>
<p style="position:absolute;top:346px;left:196px;white-space:nowrap" class="ft40">N-(adamant-1-yl)-1-(4-fluorobensyl)-1H-indazol-3-karboxamid (FUB-</p>
<p style="position:absolute;top:364px;left:181px;white-space:nowrap" class="ft40">AKB48)</p>
<p style="position:absolute;top:381px;left:196px;white-space:nowrap" class="ft40">metyl-2-(1-(4-fluorobensyl)-1H-indazol-3-karboxamido)-3-metylbutanoat</p>
<p style="position:absolute;top:399px;left:181px;white-space:nowrap" class="ft40">(FUB-AMB)</p>
<p style="position:absolute;top:416px;left:196px;white-space:nowrap" class="ft40">metyl-2-([1-(5-fluoropentyl)-1H-indol-3-yl]karboxamido)-3-metyl-</p>
<p style="position:absolute;top:433px;left:181px;white-space:nowrap" class="ft40">butanoat (I-AMB)</p>
<p style="position:absolute;top:451px;left:196px;white-space:nowrap" class="ft40">metyl-2-(1-(cyklohexylmetyl)-1H-indol-3-karboxamido)-3,3-dimetyl-</p>
<p style="position:absolute;top:468px;left:181px;white-space:nowrap" class="ft40">butanoat (MMB-CHMINACA, MDMB-CHMICA)</p>
<p style="position:absolute;top:486px;left:196px;white-space:nowrap" class="ft43">(4-metylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl)metanon (mepirapim)<br/>naftalen-1-yl-1-(5-fluoropentyl)-1H-indol-3-karboxylat (NM-2201)<br/>N-(1-amino-3-fenyl-1-oxopropan-2-yl)-1-(5-fluoropentyl)-1H-indol-3-kar-</p>
<p style="position:absolute;top:538px;left:181px;white-space:nowrap" class="ft40">boxamid (PX-1)</p>
<p style="position:absolute;top:555px;left:196px;white-space:nowrap" class="ft40">N-(1-amino-3-fenyl-1-oxopropan-2-yl)-1-(5-fluoropentyl)-1H-indazol-3-</p>
<p style="position:absolute;top:573px;left:181px;white-space:nowrap" class="ft40">karboxamid (PX-2)</p>
<p style="position:absolute;top:590px;left:196px;white-space:nowrap" class="ft43">naftalen-1-yl-(1-pentyl-1H-indazol-3-yl)metanon (THJ-018)<br/>1-(3,4-metylendioxifenyl)-2-(pyrrolidin-1-yl)butan-1-on (MDPBP)<br/>2-(pyrrolidin-1-yl)-1-(tiofen-2-yl)butan-1-on (alfa-PBT)<br/>2-(pyrrolidin-1-yl)-1-(tiofen-2-yl)pentan-1-on (alfa-PVT)<br/>1-(4-metylfenyl)-2-(pyrrolidin-1-yl)hexan-1-on (MPHP)<br/>1-(4-klorofenyl)-2-(pyrrolidin-1-yl)propan-1-on (4Cl-alfa-PPP)<br/>1-fenyl-2-(pyrrolidin-1-yl)hexan-1-on (alfa-PHP)<br/>1-fenyl-2-(pyrrolidin-1-yl)heptan-1-on (alfa-PEP)<br/>1-(2,3-dihydro-1-bensofuran-5-yl)propan-2-amin (5-APDB)<br/>1-(2,3-dihydro-1-bensofuran-6-yl)propan-2-amin (6-APDB)<br/>1-(1-bensofuran-6-yl)-N-metylpropan-2-amin (6-MAPB)<br/>2-(etylamino)-1-(4-metylfenyl)pentan-1-on (N-etyl-4-metylnorpente-</p>
<p style="position:absolute;top:799px;left:181px;white-space:nowrap" class="ft40">dron)</p>
<p style="position:absolute;top:816px;left:196px;white-space:nowrap" class="ft40">metyl-2-(1-(5-fluoropentyl)-1H-indazol-3-karboxamido)-3,3-dimetyl-</p>
<p style="position:absolute;top:834px;left:181px;white-space:nowrap" class="ft40">butanoat (5F-MDMB-PINACA)</p>
<p style="position:absolute;top:851px;left:196px;white-space:nowrap" class="ft40">[1-[(tetrahydro-2H-pyran-4-yl)metyl]-1H-indol-3-yl](2,2,3,3-tetrametyl-</p>
<p style="position:absolute;top:868px;left:181px;white-space:nowrap" class="ft40">cyklopropyl)metanon (A-834735)</p>
<p style="position:absolute;top:886px;left:196px;white-space:nowrap" class="ft40">N-(adamantan-2-yl)-1-[(tetrahydro-2H-pyran-4-yl)metyl]-1H-indazol-3-</p>
<p style="position:absolute;top:903px;left:181px;white-space:nowrap" class="ft40">karboxamid (adamantyl-THPINACA)</p>
</div>
<div id="page5-div" style="position:relative;width:701px;height:1028px;">
<img width="701" height="1028" src="/Static/i/lagboken/hidden.png" alt="background image"/>
<p style="position:absolute;top:924px;left:649px;white-space:nowrap" class="ft50">5</p>
<p style="position:absolute;top:51px;left:536px;white-space:nowrap" class="ft51"><b>SFS 2015:997</b></p>
<p style="position:absolute;top:51px;left:91px;white-space:nowrap" class="ft50">N-(1-amino-3,3-dimetyl-1-oxobutan-2-yl)-1-(cyklohexylmetyl)-1H-indol-</p>
<p style="position:absolute;top:68px;left:77px;white-space:nowrap" class="ft50">3-karboxamid (ADB-CHMICA)</p>
<p style="position:absolute;top:85px;left:91px;white-space:nowrap" class="ft50">N-(1-amino-3-fenyl-1-oxopropan-2-yl)-1-(4-fluorobensyl)-1H-indazol-3-</p>
<p style="position:absolute;top:103px;left:77px;white-space:nowrap" class="ft50">karboxamid (APP-FUBINACA)</p>
<p style="position:absolute;top:120px;left:91px;white-space:nowrap" class="ft53">naftalen-1-yl-(9-pentyl-9H-karbazol-3-yl)metanon (EG-018)<br/>(1-(4-fluorobensyl)-1H-indol-3-yl)(2,2,3,3-tetrametylcyklopropyl)meta-</p>
<p style="position:absolute;top:155px;left:77px;white-space:nowrap" class="ft50">non (FUB-144)</p>
<p style="position:absolute;top:172px;left:91px;white-space:nowrap" class="ft53">kinolin-8-yl-1-pentyl-1H-indazol-3-karboxylat (PB-22 indazol)<br/>N-(1-amino-3-metyl-1-oxobutan-2-yl)-1-(2-fluoropentyl)-1H-indazol-3-</p>
<p style="position:absolute;top:207px;left:77px;white-space:nowrap" class="ft50">karboxamid (AB-PINACA N-(2-fluoropentyl) isomer, 2F-AB-PINACA)</p>
<p style="position:absolute;top:225px;left:91px;white-space:nowrap" class="ft50">N-(1-amino-3-fenyl-1-oxopropan-2-yl)-1-(cyklohexylmetyl)-1H-indazol-</p>
<p style="position:absolute;top:242px;left:77px;white-space:nowrap" class="ft50">3-karboxamid (APP-CHMINACA)</p>
<p style="position:absolute;top:259px;left:91px;white-space:nowrap" class="ft53">N-(adamantyl)-1-(5-kloropentyl)-1H-indazol-3-karboxamid (5C-AKB48)<br/>metyl-2-(1-(4-fluorobensyl)-1H-indol-3-karboxamido)-3,3-dimetylbuta-</p>
<p style="position:absolute;top:294px;left:77px;white-space:nowrap" class="ft50">noat (MDMB-FUBICA)</p>
<p style="position:absolute;top:312px;left:91px;white-space:nowrap" class="ft50">metyl-2-(1-(4-fluorobensyl)-1H-indazol-3-karboxamido)-3,3-dimetyl-</p>
<p style="position:absolute;top:329px;left:77px;white-space:nowrap" class="ft50">butanoat (MDMB-FUBINACA)</p>
<p style="position:absolute;top:346px;left:91px;white-space:nowrap" class="ft53">naftalen-1-yl-1-pentyl-1H-indazol-3-karboxylat (SDB-005)<br/>N-(1-amino-3,3-dimetyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazol-</p>
<p style="position:absolute;top:381px;left:77px;white-space:nowrap" class="ft50">3-karboxamid (5F-ADB-PINACA)</p>
<p style="position:absolute;top:399px;left:91px;white-space:nowrap" class="ft53">N-etyl-1,2-difenyletanamin (efenidin, NEDPA)<br/>N-(1,2-difenyletyl)propan-2-amin (NPDPA)<br/>N-[1-(2-fenyletyl)piperidin-4-yl]-N-(4-fluorofenyl)butanamid (4-fluoro-</p>
<p style="position:absolute;top:451px;left:77px;white-space:nowrap" class="ft50">butyrfentanyl, 4F-BF)</p>
<p style="position:absolute;top:468px;left:91px;white-space:nowrap" class="ft53">1-(4-klorofenyl)-2-(metylamino)propan-1-on (4-CMC, klefedron)<br/>1-(3-klorofenyl)-2-(metylamino)propan-1-on (3-CMC, klofedron)<br/>1-(4-bromofenyl)-2-(metylamino)propan-1-on (brefedron, 4-BMC)<br/>2-amino-1-(4-bromo-2,5-dimetoxifenyl)etanon (bk-2C-B)<br/>(1-(5-fluoropentyl)-1H-indazol-3-yl)(pyrrolidin-1-yl)metanon (5F-PY-</p>
<p style="position:absolute;top:555px;left:77px;white-space:nowrap" class="ft50">PINACA)</p>
<p style="position:absolute;top:573px;left:91px;white-space:nowrap" class="ft50">(1-(5-fluoropentyl)-1H-indol-3-yl)(pyrrolidin-1-yl)metanon (5F-PY-</p>
<p style="position:absolute;top:590px;left:77px;white-space:nowrap" class="ft50">PICA)</p>
<p style="position:absolute;top:607px;left:91px;white-space:nowrap" class="ft50">etyl-2-(1-[4-fluorobensyl]-1H-indazol-3-karboxamido)-3-metylbutanoat</p>
<p style="position:absolute;top:625px;left:77px;white-space:nowrap" class="ft50">(EMB-FUBINACA)</p>
<p style="position:absolute;top:642px;left:91px;white-space:nowrap" class="ft50">etyl-2-(1-[5-fluoropentyl]-1H-indazol-3-karboxamido)-3-metylbutanoat</p>
<p style="position:absolute;top:660px;left:77px;white-space:nowrap" class="ft50">(5F-EMB-PINACA)</p>
<p style="position:absolute;top:677px;left:91px;white-space:nowrap" class="ft50">metyl-2-(9-(cyklohexylmetyl)-9H-karbazol-3-karboxamido)-3,3-dimetyl-</p>
<p style="position:absolute;top:694px;left:77px;white-space:nowrap" class="ft50">butanoat (MDMB-CHMCZCA)</p>
<p style="position:absolute;top:712px;left:91px;white-space:nowrap" class="ft50">N,N-dietyl-6-metyl-1-propionyl-9,10-didehydroergolin-8-karboxamid </p>
<p style="position:absolute;top:729px;left:77px;white-space:nowrap" class="ft50">(1p-LSD)</p>
<p style="position:absolute;top:747px;left:91px;white-space:nowrap" class="ft50">2-[(metylamino)metyl]-3,4-dihydro-(2H)-naftalen-1-on (meftetramin,</p>
<p style="position:absolute;top:764px;left:77px;white-space:nowrap" class="ft50">MTTA)</p>
<p style="position:absolute;top:781px;left:91px;white-space:nowrap" class="ft50">1-(2,3-dihydrobensofuran-5-yl)-2-(pyrrolidin-1-yl)pentan-1-on </p>
<p style="position:absolute;top:799px;left:77px;white-space:nowrap" class="ft50">(5-DBFPV)</p>
<p style="position:absolute;top:816px;left:91px;white-space:nowrap" class="ft50">1-(3,4-dimetoxifenyl)-2-(pyrrolidin-1-yl)pentan-1-on (3,4-dimetoxi-alfa-</p>
<p style="position:absolute;top:834px;left:77px;white-space:nowrap" class="ft50">PVP)</p>
<p style="position:absolute;top:851px;left:91px;white-space:nowrap" class="ft50">1-(3,4-dimetoxifenyl)-2-(pyrrolidin-1-yl)hexan-1-on (3,4-dimetoxi-alfa-</p>
<p style="position:absolute;top:868px;left:77px;white-space:nowrap" class="ft50">PHP)</p>
<p style="position:absolute;top:886px;left:91px;white-space:nowrap" class="ft53">1-(4-fluorofenyl)-2-(pyrrolidin-1-yl)heptan-1-on (4F-alfa-PEP)<br/>1-fenyl-2-(pyrrolidin-1-yl)oktan-1-on (alfa-POP)<br/>1-(4-metoxifenyl)-2-(pyrrolidin-1-yl)propan-1-on (4-MeO-alfa-PPP)</p>
</div>
<div id="page6-div" style="position:relative;width:701px;height:1028px;">
<img width="701" height="1028" src="/Static/i/lagboken/hidden.png" alt="background image"/>
<p style="position:absolute;top:924px;left:46px;white-space:nowrap" class="ft60">6</p>
<p style="position:absolute;top:51px;left:46px;white-space:nowrap" class="ft61"><b>SFS 2015:997</b></p>
<p style="position:absolute;top:946px;left:571px;white-space:nowrap" class="ft62">Wolters Kluwer</p>
<p style="position:absolute;top:956px;left:532px;white-space:nowrap" class="ft62">Elanders Sverige AB, 2015</p>
<p style="position:absolute;top:51px;left:196px;white-space:nowrap" class="ft63">2-(etylamino)-1-(2-metylfenyl)propan-1-on (2-MEC)<br/>3-metoxi-2-(metylamino)-1-(4-metylfenyl)propan-1-on (mexedron, </p>
<p style="position:absolute;top:85px;left:181px;white-space:nowrap" class="ft60">4-MMC-OMe)</p>
<p style="position:absolute;top:103px;left:196px;white-space:nowrap" class="ft60">N-[1-(2-fenyletyl)piperidin-4-yl]-N-(4-metoxifenyl)butanamid </p>
<p style="position:absolute;top:120px;left:181px;white-space:nowrap" class="ft60">(4-metoxibutyrfentanyl, 4-MeO-BF)</p>
<p style="position:absolute;top:138px;left:196px;white-space:nowrap" class="ft60">N-fenyl-N-[1-(2-fenyletyl)piperidin-4-yl]furan-2-karboxamid (furanyl-</p>
<p style="position:absolute;top:155px;left:181px;white-space:nowrap" class="ft60">fentanyl, Fu-F)</p>
<p style="position:absolute;top:172px;left:196px;white-space:nowrap" class="ft63">salvinorin A<br/>alla delar av v�xten Salvia divinorum fr�n vilka salvinorin A inte blivit</p>
<p style="position:absolute;top:207px;left:181px;white-space:nowrap" class="ft60">extraherat och oavsett under vilka ben�mningar de f�rekommer</p>
<p style="position:absolute;top:242px;left:196px;white-space:nowrap" class="ft60">Salter av �mnena n�r s�dana kan f�rekomma.</p>
</div>
</div>
1
Svensk f�rfattningssamling
F�rordning
om �ndring i f�rordningen (1999:58) om f�rbud
mot vissa h�lsofarliga varor;
utf�rdad den 17 december 2015.
Regeringen f�reskriver
1 att bilagan till f�rordningen (1999:58) om f�rbud
mot vissa h�lsofarliga varor ska ha f�ljande lydelse.
Denna f�rordning tr�der i kraft den 26 januari 2016.
P� regeringens v�gnar
GABRIEL WIKSTR�M
Lars Hedengran
(Socialdepartementet)
1 Se Europaparlamentets och r�dets direktiv (EU) 2015/1535 av den 9 september 2015
om ett informationsf�rfarande betr�ffande tekniska f�reskrifter och betr�ffande f�re-
skrifter f�r informationssamh�llets tj�nster.
SFS 2015:997
Utkom fr�n trycket
den 29 december 2015
2
SFS 2015:997
Bilaga
2
F�rteckning �ver varor som ska anses som h�lsofarliga varor
enligt lagen om f�rbud mot vissa h�lsofarliga varor
N-metyl-1-(3,4-metylendioxifenyl)-2-butylamin (MBDB)
1-(3,4-metylendioxifenyl)-2-butylamin (BDB)
5-metoxi-N,N-dimetyltryptamin (5-MeO-DMT)
5-metoxi-N,N-diisopropyltryptamin (5-MeO-DIPT)
5-metoxi-alfametyltryptamin (5-MeO-AMT)
2,5-dimetoxi-4-etylfenetylamin (2C-E)
alfa-metyltryptamin (AMT)
2,5-dimetoxi-4-klorfenetylamin (2C-C)
2,5-dimetoxi-4-metylfenetylamin (2C-D)
4-acetoxi-N,N-diisopropyltryptamin (4-AcO-DIPT)
4-hydroxi-N,N-diisopropyltryptamin (4-HO-DIPT)
gammabutyrolakton (GBL)
1,4-butandiol (1,4-BD)
4-acetoxi-N,N-metylisopropyltryptamin (4-AcO-MIPT)
4-hydroxi-N,N-metylisopropyltryptamin (4-HO-MIPT)
4-acetoxi-N,N-dietyltryptamin (4-AcO-DET)
4-hydroxi-N,N-dietyltryptamin (4-HO-DET)
1-(3-trifluormetylfenyl)piperazin (TFMPP)
2,5-dimetoxi-4-isopropyltiofenetylamin (2C-T-4)
[2,3-dihydro-5-metyl-3-(4-morfolinylmetyl)pyrrolo[1,2,3-de]-1,4-
bensoxazin-6-yl]-1-naftalenylmetanon (WIN 55,212-2)
5-(1,1-dimetylheptyl)-2-[5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]fenol
(CP 55,940)
(2-metyl-1-pentylindol-3-yl)-(naftalen-1-yl)metanon (JWH-007)
(2-metyl-1-propyl-1H-indol-3-yl)-1-naftalenylmetanon (JWH-015)
(1-hexyl-1H-indol-3-yl)-1-naftalenylmetanon (JWH-019)
2-metylnaftalen-1-yl-(butylindol-3-yl)metanon (JWH-073 metylderivat)
4-metoxinaftalen-1-yl-(1-pentylindol-2-metyl-3-yl)metanon (JWH-098)
1-hexyl-2-fenyl-4-(1-naftoyl)pyrrol (JWH-147)
(4-metoxyfenyl)(1-pentyl-1H-indol-3-yl)metanon (RCS-4)
4-metylhexan-2-amin (DMAA)
4-(2-aminopropyl)bensofuran (4-APB)
5-(2-aminopropyl)bensofuran (5-APB)
6-(2-aminopropyl)bensofuran (6-APB)
(1-pentyl-1H-indol-3-yl)(2,2,3,3-tetrametylcyclopropyl)metanon
(UR-144)
1-(1-bensofuran-5-yl)-N-metylpropan-2-amin (5-MAPB)
1-(5-fluoropentyl)-N-tricyklo[3.3.1.1
3,7]dek-1-yl-1H-indol-3-karboxamid
(STS-135)
1-pentyl-N-tricyklo[3.3.1.1
3,7]dek-1-yl-1H-indol-3-karboxamid (APICA
[JWH-018 adamantyl karboxamid])
1-pentyl-N-tricyklo[3.3.1.1
3,7]dek-1-yl-1H-indazol-3-karboxamid
(AKB48)
(1-pentyl-1H-indol-3-yl)tricyklo[3.3.1.1
3,7]dek-1-yl-metanon (AB-001)
2 Senaste lydelse 2015:525.
3
SFS 2015:997
(1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetrametylcyklopropyl)met-
anon (5F-UR-144)
1-(5-fluoropentyl)-1H-indol-3-karboxylsyra 8-kinolinester (5F-PB22)
1-(5-fluoropentyl)-N-tricyklo[3.3.1.1
3,7]dek-1-yl-1H-indazol-3-karbox-
amid (5F-AKB48)
1-[(5-kloropentyl)-1H-indol-3-yl]-(naftalen-1-yl)metanon (JWH-018
N-[5-kloropentyl] derivat)
N-[1-(aminokarbonyl)-2-metylpropyl]-1-[(4-fluorofenyl)metyl]-1H-
indazol-3-karboxamid (AB-FUBINACA)
N-(1-amino-3,3-dimetyl-1-oxobutan-2-yl)-1-((4-fluorofenyl)metyl)-1H-
indazol-3-karboxamid (ADB-FUBINACA)
N-[1-(aminokarbonyl)-2-metylpropyl]-1-(cyclohexylmetyl)-1H-indazol-3-
karboxamid (AB-CHMINACA)
N-(1-amino-3-metyl-1-oxobutan-2-yl)-1-pentyl-1H-indazol-3-karboxamid
(AB-PINACA)
N-(1-amino-3-metyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazol-3-
karboxamid (5F-AB-PINACA)
N-(1-amino-3,3-dimetyl-1-oxobutan-2-yl)-1-pentyl-1H-indol-3-karboxa-
mid (ADBICA)
kinolin-8-yl-1-pentyl-1H-indol-3-karboxylat (PB-22)
kinolin-8-yl-1-(4-fluorobensyl)-1H-indol-3-karboxylat (FUB-PB-22)
naftalen-1-yl-1-(4-fluorobensyl)-1H-indol-3-karboxylat (FDU-PB-22)
kinolin-8-yl-1-(5-fluoropentyl)-1H-indazol-3-karboxylat (5F-PB-22
indazol)
kinolin-8-yl-1-(cyklohexylmetyl)-1H-indol-3-karboxylat (BB-22)
4-hydroxi-3,3,4-trimetyl-1-(1-pentyl-1H-indol-3-yl)pentan-1-on
(4-HTMPIPO)
(1-heptyl-1H-indol-3-yl)(2,2,3,3-tetrametylcyklopropyl)metanon
(UR-144-heptylderivat)
N-bensyl-1-(5-fluoropentyl)-1H-indol-3-karboxamid (5F-SDB-006)
N-bensyl-1-pentyl-1H-indol-3-karboxamid (SDB-006)
N-(1-amino-3,3-dimetyl-1-oxobutan-2-yl)-1-pentyl-1H-indazol-3-
karboxamid (ADB-PINACA)
N-(naftalen-1-yl)-1-pentyl-1H-indazol-3-karboxamid (MN-18)
1-(5-fluoropentyl)-N-(naftalen-1-yl)-1H-indol-3-karboxamid (5F-NNEI)
N-(1-amino-3-metyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indol-3-
karboxamid (5F-AB-144)
(1-(5-fluoropentyl)-1H-indazol-3-yl)(naftalen-1-yl)metanon (THJ-2201)
[1-(5-fluoropentyl)-1H-benso[d]imidazol-2-yl](naftalen-1-yl)metanon
(FUBIMINA)
metyl-2-(1-(5-fluoropentyl)-1H-indazol-3-karboxamido)-3-metylbutanoat
(5F-AMB)
1-(5-fluoropentyl)-N-(naftalen-1-yl)-1H-indazol-3-karboxamid (5F-MN-
18)
1-(5-fluoropentyl)-N-(naftalen-1-yl)-1H-pyrrolo[3,2-c]pyridin-3-karbo-
xamid (5F-PCN)
naftalen-1-yl-1-(5-fluoropentyl)-1H-indazol-3-karboxylat (5F-SDB-005)
N-(1-amino-3-metyl-1-oxobutan-2-yl)-1-[(2-fluorofenyl)metyl]-1H-inda-
zol-3-karboxamid (AB-FUBINACA 2-fluorobensyl isomer)
N-(1-amino-3,3-dimetyl-1-oxobutan-2-yl)-1-(cyklohexylmetyl)-1H-inda-
zol-3-karboxamid (ADB-CHMINACA)
4
SFS 2015:997
7-kloro-N-[1-[((2-((cyklopropylsulfonyl)amino)-etyl)amino)karbonyl]-
2,2-dimetyl-propyl]-1-(4-fluorobensyl)-1H-indazol-3-karboxamid (ADSB-
FUB-187)
adamant-1-yl-(1-[(N-metylpiperidin-2-yl)metyl]-1H-indol-3-yl)metanon
(AM-1248)
N-(2-fenylpropan-2-yl)-1-(5-fluoropentyl)-1H-indol-3-karboxamid
(CUMYL-5F-PICA)
1-(5-fluoropentyl)-N-(2-fenylpropan-2-yl)-1H-indazol-3-karboxamid
(CUMYL-5F-PINACA, SGT-25)
1-butyl-N-(2-fenylpropan-2-yl)-1H-indol-3-karboxamid (CUMYL-BICA)
N-(2-fenylpropan-2-yl)-1-pentyl-1H-indol-3-karboxamid (CUMYL-PICA)
N-(2-fenylpropan-2-yl)-1-pentyl-1H-indazol-3-karboxamid (CUMYL-
PINACA)
N-(2-fenylpropan-2-yl)-1-((tetrahydro-2H-pyran-4-yl)metyl)-1H-indazol-
3-karboxamid (CUMYL-THPINACA)
(1-(5-fluoropentyl)-1H-indazol-3-yl)(2,2,3,3-tetrametylcyklopropyl)meta-
non (FAB-144)
N-(adamant-1-yl)-1-(4-fluorobensyl)-1H-indazol-3-karboxamid (FUB-
AKB48)
metyl-2-(1-(4-fluorobensyl)-1H-indazol-3-karboxamido)-3-metylbutanoat
(FUB-AMB)
metyl-2-([1-(5-fluoropentyl)-1H-indol-3-yl]karboxamido)-3-metyl-
butanoat (I-AMB)
metyl-2-(1-(cyklohexylmetyl)-1H-indol-3-karboxamido)-3,3-dimetyl-
butanoat (MMB-CHMINACA, MDMB-CHMICA)
(4-metylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl)metanon (mepirapim)
naftalen-1-yl-1-(5-fluoropentyl)-1H-indol-3-karboxylat (NM-2201)
N-(1-amino-3-fenyl-1-oxopropan-2-yl)-1-(5-fluoropentyl)-1H-indol-3-kar-
boxamid (PX-1)
N-(1-amino-3-fenyl-1-oxopropan-2-yl)-1-(5-fluoropentyl)-1H-indazol-3-
karboxamid (PX-2)
naftalen-1-yl-(1-pentyl-1H-indazol-3-yl)metanon (THJ-018)
1-(3,4-metylendioxifenyl)-2-(pyrrolidin-1-yl)butan-1-on (MDPBP)
2-(pyrrolidin-1-yl)-1-(tiofen-2-yl)butan-1-on (alfa-PBT)
2-(pyrrolidin-1-yl)-1-(tiofen-2-yl)pentan-1-on (alfa-PVT)
1-(4-metylfenyl)-2-(pyrrolidin-1-yl)hexan-1-on (MPHP)
1-(4-klorofenyl)-2-(pyrrolidin-1-yl)propan-1-on (4Cl-alfa-PPP)
1-fenyl-2-(pyrrolidin-1-yl)hexan-1-on (alfa-PHP)
1-fenyl-2-(pyrrolidin-1-yl)heptan-1-on (alfa-PEP)
1-(2,3-dihydro-1-bensofuran-5-yl)propan-2-amin (5-APDB)
1-(2,3-dihydro-1-bensofuran-6-yl)propan-2-amin (6-APDB)
1-(1-bensofuran-6-yl)-N-metylpropan-2-amin (6-MAPB)
2-(etylamino)-1-(4-metylfenyl)pentan-1-on (N-etyl-4-metylnorpente-
dron)
metyl-2-(1-(5-fluoropentyl)-1H-indazol-3-karboxamido)-3,3-dimetyl-
butanoat (5F-MDMB-PINACA)
[1-[(tetrahydro-2H-pyran-4-yl)metyl]-1H-indol-3-yl](2,2,3,3-tetrametyl-
cyklopropyl)metanon (A-834735)
N-(adamantan-2-yl)-1-[(tetrahydro-2H-pyran-4-yl)metyl]-1H-indazol-3-
karboxamid (adamantyl-THPINACA)
5
SFS 2015:997
N-(1-amino-3,3-dimetyl-1-oxobutan-2-yl)-1-(cyklohexylmetyl)-1H-indol-
3-karboxamid (ADB-CHMICA)
N-(1-amino-3-fenyl-1-oxopropan-2-yl)-1-(4-fluorobensyl)-1H-indazol-3-
karboxamid (APP-FUBINACA)
naftalen-1-yl-(9-pentyl-9H-karbazol-3-yl)metanon (EG-018)
(1-(4-fluorobensyl)-1H-indol-3-yl)(2,2,3,3-tetrametylcyklopropyl)meta-
non (FUB-144)
kinolin-8-yl-1-pentyl-1H-indazol-3-karboxylat (PB-22 indazol)
N-(1-amino-3-metyl-1-oxobutan-2-yl)-1-(2-fluoropentyl)-1H-indazol-3-
karboxamid (AB-PINACA N-(2-fluoropentyl) isomer, 2F-AB-PINACA)
N-(1-amino-3-fenyl-1-oxopropan-2-yl)-1-(cyklohexylmetyl)-1H-indazol-
3-karboxamid (APP-CHMINACA)
N-(adamantyl)-1-(5-kloropentyl)-1H-indazol-3-karboxamid (5C-AKB48)
metyl-2-(1-(4-fluorobensyl)-1H-indol-3-karboxamido)-3,3-dimetylbuta-
noat (MDMB-FUBICA)
metyl-2-(1-(4-fluorobensyl)-1H-indazol-3-karboxamido)-3,3-dimetyl-
butanoat (MDMB-FUBINACA)
naftalen-1-yl-1-pentyl-1H-indazol-3-karboxylat (SDB-005)
N-(1-amino-3,3-dimetyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazol-
3-karboxamid (5F-ADB-PINACA)
N-etyl-1,2-difenyletanamin (efenidin, NEDPA)
N-(1,2-difenyletyl)propan-2-amin (NPDPA)
N-[1-(2-fenyletyl)piperidin-4-yl]-N-(4-fluorofenyl)butanamid (4-fluoro-
butyrfentanyl, 4F-BF)
1-(4-klorofenyl)-2-(metylamino)propan-1-on (4-CMC, klefedron)
1-(3-klorofenyl)-2-(metylamino)propan-1-on (3-CMC, klofedron)
1-(4-bromofenyl)-2-(metylamino)propan-1-on (brefedron, 4-BMC)
2-amino-1-(4-bromo-2,5-dimetoxifenyl)etanon (bk-2C-B)
(1-(5-fluoropentyl)-1H-indazol-3-yl)(pyrrolidin-1-yl)metanon (5F-PY-
PINACA)
(1-(5-fluoropentyl)-1H-indol-3-yl)(pyrrolidin-1-yl)metanon (5F-PY-
PICA)
etyl-2-(1-[4-fluorobensyl]-1H-indazol-3-karboxamido)-3-metylbutanoat
(EMB-FUBINACA)
etyl-2-(1-[5-fluoropentyl]-1H-indazol-3-karboxamido)-3-metylbutanoat
(5F-EMB-PINACA)
metyl-2-(9-(cyklohexylmetyl)-9H-karbazol-3-karboxamido)-3,3-dimetyl-
butanoat (MDMB-CHMCZCA)
N,N-dietyl-6-metyl-1-propionyl-9,10-didehydroergolin-8-karboxamid
(1p-LSD)
2-[(metylamino)metyl]-3,4-dihydro-(2H)-naftalen-1-on (meftetramin,
MTTA)
1-(2,3-dihydrobensofuran-5-yl)-2-(pyrrolidin-1-yl)pentan-1-on
(5-DBFPV)
1-(3,4-dimetoxifenyl)-2-(pyrrolidin-1-yl)pentan-1-on (3,4-dimetoxi-alfa-
PVP)
1-(3,4-dimetoxifenyl)-2-(pyrrolidin-1-yl)hexan-1-on (3,4-dimetoxi-alfa-
PHP)
1-(4-fluorofenyl)-2-(pyrrolidin-1-yl)heptan-1-on (4F-alfa-PEP)
1-fenyl-2-(pyrrolidin-1-yl)oktan-1-on (alfa-POP)
1-(4-metoxifenyl)-2-(pyrrolidin-1-yl)propan-1-on (4-MeO-alfa-PPP)
6
SFS 2015:997
Wolters Kluwer
Elanders Sverige AB, 2015
2-(etylamino)-1-(2-metylfenyl)propan-1-on (2-MEC)
3-metoxi-2-(metylamino)-1-(4-metylfenyl)propan-1-on (mexedron,
4-MMC-OMe)
N-[1-(2-fenyletyl)piperidin-4-yl]-N-(4-metoxifenyl)butanamid
(4-metoxibutyrfentanyl, 4-MeO-BF)
N-fenyl-N-[1-(2-fenyletyl)piperidin-4-yl]furan-2-karboxamid (furanyl-
fentanyl, Fu-F)
salvinorin A
alla delar av v�xten Salvia divinorum fr�n vilka salvinorin A inte blivit
extraherat och oavsett under vilka ben�mningar de f�rekommer
Salter av �mnena n�r s�dana kan f�rekomma.